IRIS
SAVERINO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.279
Totale 12.279
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.279
Totale 12.279
Salva come PNG Salva come JPEG
Città #
Genova 9.089
Genoa 1.506
Rapallo 1.370
Vado Ligure 290
Bordighera 24
Totale 12.279
Salva come PNG Salva come JPEG
Nome #
Natural analogue peptides of an HIV-1 GP120 T-helper epitope antagonize response of GP120-specific human CD4 T-cell clones. 233
L'azitromicina induce l'eliminazione di diversi plasmodi in Klebsiella pneumoniae- 158
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein. 146
Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime. 143
Attenuated Listeria monocytogenes carrier strains can deliver an HIV-1 gp120 T helper epitope to MHC class II-restricted human CD4+ T cells. 141
Are cultured stromal cells a suitable model to study osteopathic manipulative treatment (OMT) ‘in vitro’? A first experimental approach 139
Anti-HIV genetic treatment of antigen-specific human CD4 lymphocytes for adoptive immunotherapy of opportunistic infections in AIDS. 138
Human T leukaemia virus type 1 (HTLV-1) specific T-helper cell response: clonal fluctuations and repertoire heterogeneity. 137
Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies. 131
CD277 an Immune Regulator of T Cell Function and Tumor Cell Recognition 131
Net effect of inoculum size on antimicrobial action of ampicillin-sulbactam: studies using an in vitro dynamic model. 129
Escherichia coli isolated from human polymicrobial bacteriuria are able to suppress in vitro interleukin production 129
Soluble CTLA-4 in autoimmune thyroid diseases: Relationship with clinical status and possible role in the immune response dysregulation 127
Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC. 126
Quinolone/fluoroquinolone susceptibility in Escherichia coli correlates with human polymicrobial bacteriuria and with in vitro interleukine-8 suppression. 126
CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells. 126
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. 125
Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels. 123
Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection. 123
Immune Response to Rotavirus and Gluten Sensitivity 118
THE SOLUBLE FORM OF CTLA-4 FROM SERUM OF PATIENTS WITH AUTOIMMUNE DISEASES REGULATES T-CELL RESPONSES. 116
Apoptosis of squamous cells at different stages of carcinogenesis following 4-HPR treatment 116
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum ctla-4 and IL-10. 115
Stimulation of Human CD4+ T Lymphocytes via TLR3, TLR5 and TLR7/8 Up-Regulates Expression of Costimulatory and Modulates Proliferation 115
CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis 114
Serum cytotoxic T lymphocyte-associated antigen 4 in hymenoptera venom allergy and its modulation by specific immunotherapy 114
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury 113
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. 112
Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis. 112
Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. 112
SERUM LAIR-2 IS INCREASED IN AUTOIMMUNE THYROID DISEASES 110
Handling of retroviral antigens by human antigen-presenting cells 110
The frequency of T regulatory cells is increased in peripheral blood of patients with colon-rectal cancer. 110
The frequency of regulatory CD3+CD8+CD28-CD25+ T lymphocytes in human peripheral blood increases with age. 109
CD1d expression and function in B-cell lymphoproliferative disorders 108
Evaluation of neuroendocrine parameters during osteopathic manipulative treatment (OMT) 108
Oversecretion of soluble CTLA-4 in various autoimmune diseases overlapping celiac disease. 107
BT3 molecules ligation enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. 106
Death of T cell precursors in the human thymus: a role for CD38 106
Observational Study on the Occurrence of Muscle Spindles in Human Digastric and Mylohyoideus Muscles 104
High levels of soluble ctla-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis. 104
The inhibitory co-receptors: a way to save from anergy the HIV-specific T cells. 103
Cranberry polyphenols regulate in vitro human T cell responses induced by E.coli bacteria isolated from urinary infection. 103
CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion 103
Antibacterial profile of flurithromycin, a new macrolide 102
Cytokine gene expression and T-cell proliferative responses in lymph node mononuclear cells from children with early stage human immunodeficiency virus infection. 101
Inhibitory receptors CD85j, LAIR-1 and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes 101
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 101
The Role of CTLA-4 Gene Polymorphisms in Autoimmune Disease Pathogenesis: A 2012 Update 100
Anti-inflammatory and stress responses after intense vs moderate judo exercise in children 100
CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor. 100
Anti-inflammatory and stress responses after intense vs moderate judo exercise in children. 99
Estimate of the Prevalence of Anti-Gastric Parietal Cell Autoantibodies in Healthy Individuals Is Method Dependent 99
The soluble CTLA-4 receptor and its role in autoimmune diseases: an update 98
Effect of lentiviral vectors on the phenotypical and functional maturation of human dendritic cells: implications for gene therapy. 97
Anti-flagellin antibodies recognize the autoantigen TLR5 and Pals1-associated tight junction protein and induce monocyte activation and increase intestinal permeability in Crohn's disease 95
Effect of cefoxitin and clindamycin on selection of derepressed mutants in Enterobacter cloacae. 94
Evaluation of the post-antibiotic effect induced by various antibiotics against staphylococci and enterococci. 93
Identification of Salmonella enterica Serovar Typhi DNA Fragments with Transcriptional Activity Under Different Growth Conditions. 93
A novel inhibitory receptor regulates T-cell function. 92
Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes 92
Targeting ctla-4 directly on melanoma cells: A possible novel perspective in the immunotherapy of cutaneous melanoma. 89
Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells 89
HIV-1 resistant, antigen specific CD4 lymphocytes for adoptive therapy of acquired immune deficiency. 88
Analyses of muscle spindles in suprahyoid muscles of the humans. 87
Modification of expression of the GH-IGF system in human renal tubular epithelial cells in different endocrine and metabolic conditions 86
CTLA-4 inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonal distribute fashion. 86
F'lac integrative suppression in gyrB(Ts) mutan 85
The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions 84
Pathogenic Mechanisms in Escherichia coli Cystitis: New Perspectives Joined Together. 83
Hypothalamic expression of PD-L1: does it mediate hypothalamitis? 83
The soluble CTLA-4 receptor and its emerging role in autoimmune diseases 82
Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens. 81
Surface density expression of the leukocyte-associated Ig-like receptor-1 is directly related to inhibition of human T-cell functions. 81
Production of specific antibodies with the help of genetically treated T cells: use of anti-TAT vector for adoptive immunotherapy of AIDS. 81
In vivo and in vitro behavior of IGF system and Insulin receptor in polycystic ovaries (PCO) 81
Antistaphylococcal activity of cefdinir, a new oral third generation cephalosporin, at supra- and sub-MIC levels. 81
Il bagno d’inverno fa bene al sistema immunitario e alla psiche 81
Anti HIV genetic treatment of antigen-specific human CD4 lymphocytes for adoptive immunotherapy of AIDS. 80
Specific recognition of the viral protein UL18 by CD85j on CD8+ cells mediates the non MHC-restricted lysis of HCNV-infected cells 80
Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non MHC-restricted lysis of hCMV-infected cells. 79
FRI0480 CHANGES IN CIRCULATING SCTLA-4 FOLLOWING ZOLEDRONIC ACID INFUSION 79
In vitro antibacterial activity of azithromycin against respiratory tract pathogens, Gerdnerella vaginalis and Bacteroides group organisms. 78
Effects of winter sea bathing on psychoneuroendocrinoimmunological parameters 78
A soluble form of CTLA-4 is present in serum of paediatric patients with acute lymphoblastic leukaemia. 77
In vitro interaction of flurithromycin with other drugs employed in the therapy of respiratory infections. 77
Strategie di induzione di risposte anticorpi verso determinanti di gp120 di HIV. 77
Attività antistafilococcica del cefdinir, una nuova cefalosporina orale, in condizione di supera- e sub-MIC. 77
Hypervariability of HIV immunodominant epitopes: elusion of T helper response and antagonistic activity. 76
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. 76
The relation of ampicillin/sulbactam action to bacterial beta-lactamase production in an in vitro dynamic model. 74
Clonal heterogeneity of human Th lines specific for HTLV-1 env. 74
Antimicrobial profile of cefixime 73
Genetic treatment of antigen specific CD T cells with the use of anti-tat vector for adoptive immunotherapy of AIDS. 72
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury and tissue-transglutaminase antibody production. 72
An anti-HIV genetic treatment of antigen-specific Y human lymphocytes: use for adoptive immunotherapy of AIDS. 72
CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis 72
Antistaphylococcal activity of cefdinir alone and in combination with other drugs. 69
Recognition of human T-leukemia virus (HTLV-1) envelope by human CD4+ T-cell lines from HTLV-1 seronegative individuals: specificity and clonal heterogeneity. 69
Pharmacokinetically (PK) relevant concentration of clavulanic acid (CA) do not antagonize the in vitro killing of E. Cloacae by ticarcillin (TIC). 68
Totale 10.113
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.381
article - articoli 24.748
book - libri 182
conference - conferenze 10.789
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 662
Totale 72.762
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.860 0 0 147 167 233 302 445 165 241 577 420 163
2020/2021884 59 145 70 47 53 130 34 65 98 84 54 45
2021/20221.740 38 137 83 175 116 110 147 387 53 160 80 254
2022/20231.783 207 174 45 197 195 297 6 136 268 12 198 48
2023/20241.074 51 124 51 111 93 218 102 36 50 20 65 153
2024/2025352 94 213 45 0 0 0 0 0 0 0 0 0
Totale 12.390